Click image to enlarge
Autoimmune Hemolytic Anemia (AIHA) is a rare condition in which the body’s immune system mistakenly attacks and destroys its own red blood cells, leading to anemia. Because red blood cells are destroyed faster than they can be replaced, people with AIHA may experience fatigue, weakness, shortness of breath, pale or yellowish skin, dark urine, and an enlarged spleen. AIHA can occur on its own (primary) or in connection with other conditions such as autoimmune diseases, infections, certain cancers, or as a reaction to medications. There are two main types: warm AIHA, where antibodies attack red blood cells at body temperature, and cold AIHA, where antibodies become active in colder temperatures. Treatment depends on severity and underlying cause, and may include medications to suppress the immune system, blood transfusions, or treatment of the associated condition.
We are currently seeking volunteers for a clinical study evaluating the safety and effectiveness of a potential treatment for Autoimmune Hemolytic Anemia (AIHA).
If you or someone you know may be interested, please reach out to learn more about eligibility and the potential benefits of participation.